Aaron D. Berger, M.D. earned his Bachelor of Science degree from the University of Wisconsin with a major in biochemistry and molecular biology. Dr. Berger attended medical school at the David Geffen School of Medicine at University of California Los Angeles to earn his M.D. He completed his residency in Urology at the NYU Langone Medical Center in New York. Dr. Berger completed a fellowship at the University of California San Francisco in Laparoscopy, Endourology and Robotic Surgery. Dr. Berger is a member of the American Urological Association, the Endourological Society, the American Medical Association and the Chicago Urologic Society.
Dr. Berger is the current Chief Medical Officer and Director of Clinical Research of Associated Urological Specialists (AUS). He has a special interest in prostate cancer from robotic surgery to state of the art treatments of advanced and metastatic prostate cancer.
Large numbers of men could have missed a prostate cancer diagnosis due to Covid-19. Combine that with a rise in prostate cancer and the future looks grim. Ultimately, something in the prostate cancer diagnostic landscape needs to change: but what?